Non-alcoholic Fatty Liver Disease: all 1,507 studies
Page 8 of 16. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.
- Liver Cirrhosis Network Cohort StudyActive, not recruitingNCT05740358
- Effect of Alpelisib in Healthy VolunteersCompletedNCT05733455Phase 1
- A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney FunctionCompletedNCT05727644Phase 1
- Pancreatic Clamp in NAFLDCompletedNCT05724134Phase 1
- A Feasibility Trial of OCM Supplements for the Treatment of NAFLDCompletedNCT05720702Early Phase 1
- The Nijmegen-Leiden-Amsterdam 2-tiered Care Path StudyCompletedNCT05712603
- Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of MiricorilantCompletedNCT05712265Phase 1
- Effect of Indian Hepatoprotective Diet in Reversibility of NAFLDStatus unknownNCT05696808Not applicable
- Effect of Sodium Glucose Cotransporter Inhibitors Fatty Liver Disease Patients Fatigue AssessmentCompletedNCT05694923Not applicable
- A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)Active, not recruitingNCT05692492Phase 2
- Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLDStatus unknownNCT05686174Phase 1
- Safety Study of OA-235i in Subjects With Nonalcoholic SteatohepatitisCompletedNCT05680233Phase 1
- Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver DiseaseCompletedNCT05669677
- A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy ParticipantsTerminatedNCT05668936Phase 1
- A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy SubjectsStatus unknownNCT05655221Phase 1
- Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver DiseaseStatus unknownNCT05654129Not applicable
- The Acute Effects of Eucaloric and Hypocaloric Carbohydrate Restriction on Liver Fat Content and Metabolism in Obese IndividualsStatus unknownNCT05643521Not applicable
- SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic OutcomesStatus unknownNCT05637866
- Effects of Bacillus Coagulans on Liver and Gut Microbiota Function in NAFLDStatus unknownNCT05635474Not applicable
- HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-DiabetesCompletedNCT05623189Phase 2
- Ketotifen in Non-Alcoholic Fatty Liver Disease PatientsCompletedNCT05616442Phase 4
- Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease PatientsStatus unknownNCT05613192Phase 3
- Endoscopic Gastric Plication Using the POSE2.0 Technique for Management of Fatty Liver DiseaseCompletedNCT05611567Not applicable
- Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic SteatohepatitisStatus unknownNCT05605158Phase 3
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASHCompletedNCT05591079Phase 2
- N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver DiseaseCompletedNCT05589584Phase 3
- Phase 2b Study of GSK4532990 in Adults With NASHActive, not recruitingNCT05583344Phase 2
- Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled TrialCompletedNCT05579158Not applicable
- High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver DiseaseCompletedNCT05578404Phase 2
- Efficacy of N-Acetylcysteine in Improving/Normalizing ALT & AST in Patients of NAFLDStatus unknownNCT05576428Not applicable
- Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients with HyperuricemiaActive, not recruitingNCT05574036Phase 2
- Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic SteatohepatitisActive, not recruitingNCT05573204Phase 2
- Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver DiseaseCompletedNCT05560607Phase 1
- Evaluation of the Effects of Orange Consumption on Carbohydrate and Lipid Metabolism in Subjects With MAFLD (Metabolic Associated Fatty Liver Disease)CompletedNCT05558592Not applicable
- Role Of Serum Adiponectin In The Ealy Detection Of Renal Impairment In Patients With Non Alcoholic Fatty Liver DiseaseStatus unknownNCT05556135
- Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of MiricorilantCompletedNCT05553470Phase 1
- FTIH of ECC4703 in Healthy VolunteersCompletedNCT05552274Early Phase 1
- Weight Gain After Smoking Cessation and NAFLDCompletedNCT05550688
- Effect of Lyophilized Cornus Mas L. on Anthropometric and Biochemical Parameters in Metabolic Associated Fatty Liver Disease PatientsCompletedNCT05546450Not applicable
- Web-based Interventions on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese ChildrenCompletedNCT05527938Not applicable
- Clinical Epidemiology of NAFLD in Children and AdolescentsStatus unknownNCT05526274
- Mechanism of Serum PRL in the Development of MAFLDStatus unknownNCT05525884
- Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLDCompletedNCT05523648Early Phase 1
- Effect of Probiotics or Berberine in Hepatic Steatosis Markers, Cardiometabolic and Microbiotic Profile in NAFL.Status unknownNCT05523024Not applicable
- Exercise and Cerebral Hemodynamics in MAFLD.Status unknownNCT05520697Not applicable
- First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT05517564Phase 1
- Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05513729
- Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic SteatohepatitisActive, not recruitingNCT05507151
- Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver DiseaseCompletedNCT05506488Phase 1/2
- The Franciscus Obesity NASH StudyActive, not recruitingNCT05499949
- Treating Pediatric NAFLD with NutritionCompletedNCT05499585Not applicable
- An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT05497765Not applicable
- Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver DiseaseCompletedNCT05493761Phase 4
- Screening of Liver Fibrosis in Adults Without Known Liver DiseaseStatus unknownNCT05486767
- Evaluation of Lipid Profile in Different Grades of Non-alcoholic Fatty Liver Disease Diagnosed by UltrasoundStatus unknownNCT05486429
- Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced FibrosisCompletedNCT05485714
- Non-alcoholic Fatty Liver Disease and Its TreatmentCompletedNCT05480007Not applicable
- LITMUS Imaging StudyActive, not recruitingNCT05479721
- Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD PatientsCompletedNCT05474560Phase 4
- MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and HypertriglyceridemiaActive, not recruitingNCT05464784Phase 2
- Ketohexokinase Inhibition in NAFLDCompletedNCT05463575Phase 2
- Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASHActive, not recruitingNCT05462353Phase 2
- Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT05459701Phase 4
- Study to Assess the Safety, Tolerability, and Pharmacokinetics of PXL770 in Healthy Subjects.CompletedNCT05441904Phase 1
- A Digital Solution for Individuals With Non Alcoholic Fatty Liver DiseaseCompletedNCT05426382Not applicable
- Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)TerminatedNCT05423327Not applicable
- Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05422092Not applicable
- Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)Status unknownNCT05421572
- Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver DiseaseCompletedNCT05419765
- The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease EvolutionCompletedNCT05416970
- To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota ModulationCompletedNCT05402449Not applicable
- A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver FibrosisStatus unknownNCT05402371Phase 2
- A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic SteatohepatitisCompletedNCT05397379Phase 2
- Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis AssessmentActive, not recruitingNCT05384652
- Prevalence of NAFLD in ACS PatientsCompletedNCT05378321Not applicable
- The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to HepatologyCompletedNCT05370053Not applicable
- Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLDStatus unknownNCT05359471Not applicable
- Study of Neutrophils and Circulating Platelets in Correlation With the Activity of T Lymphocytes in Patients With NAFLD (Nonalcoholic Fatty Liver Disease)Status unknownNCT05358496
- Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH FibrosisCompletedNCT05357352
- Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASHCompletedNCT05357248Not applicable
- Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASHCompletedNCT05343780Phase 2
- Effect of Molecular Hydrogen in Patients With NAFLDCompletedNCT05325398Not applicable
- A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)CompletedNCT05320146
- Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) StudyCompletedNCT05309642Not applicable
- A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapagliflozin in Subjects With Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05308160Phase 3
- Different Doses of ZED1227 vs. Placebo in NAFLDCompletedNCT05305599Phase 2
- Omics-based Predictors of NAFLD/Potential NASHStatus unknownNCT05301231
- A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy SubjectsCompletedNCT05294458Phase 1
- Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)CompletedNCT05292911Phase 1
- Prevention of NAFLD in Hispanic ChildrenTerminatedNCT05292352Not applicable
- Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver ProgressionCompletedNCT05291104Not applicable
- Pentoxifylline in Treatment of Patients With Nonalcoholic SteatohepatitisCompletedNCT05284448Phase 3
- Effects of VLCKD in Metabolic SyndromeActive, not recruitingNCT05275608Not applicable
- Moderately Carbohydrate-restricted Diet to Treat NAFLD in AdolescentsCompletedNCT05268042Not applicable
- Ectopic Fat in Singaporean Women - the Culprit Leading to Gestational Diabetes, Metabolic Syndrome, and Type 2 Diabetes (TANGO Study)CompletedNCT05259475Not applicable
- Ursodeoxycholic Acid in Patients With NAFLD - Clinical ObservationActive, not recruitingNCT05256979
- Efficacy and Safety of Dapagliflozin in Patients with Non-alcoholic SteatohepatitisCompletedNCT05254626Phase 2
- Assocaiton Between Uric Acid Trajecteries and Remission of NAFLD in NAFLD IndividualsStatus unknownNCT05245890
- Hybrid Training and Middle AgeCompletedNCT05231564Not applicable
- Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records.Status unknownNCT05218538